Effects of Viral Lower Respiratory Tract Infection on Lung Function in Infants With Cystic Fibrosis
The DOI matches its Crossref record.
Abstract
Objective.: To determine the effect of respiratory viral infections on pulmonary function in infants with cystic fibrosis (CF) after the respiratory virus season (October through March). Methods.: Recruitment was for one respiratory virus season during a 3-year span, 1988 to 1991, with reenrollment allowed; 22 infants <2 years of age with CF (30 patient-seasons) and 27 age-matched controls (28 patient-seasons) participated. Primary outcome variables were preseason and postseason pulmonary function tests and serology for viral antibodies. Twice-weekly telephone calls screened for respiratory symptoms. The presence of respiratory symptoms triggered a home visit and an evaluation for upper or lower (LRTI) respiratory tract infection. A nasopharyngeal sample for viral culture was performed with each visit. Results.: Controls and CF infants each had a mean of 5.3 acute respiratory illnesses; CF infants were four times more likely to develop an LRTI compared with controls (odds ratio, 4.6; 95% confidence interval, 1.3 and 16.5). Three of 7 (43%) CF infants with respiratory syncytial virus infection (documented by culture) required hospitalization. Controls had no association between respiratory illness and postseason pulmonary function. For CF infants, reduced postseason maximal flow at functional residual capacity (V′maxFRC) was associated with two interactions, ie, respiratory syncytial virus infection and LRTI, and male sex and LRTI; increased gas trapping (FRC) was associated with an interaction between respiratory syncytial virus and LRTI and day care . Postseason pulmonary function tests were obtained a mean of 3.2 months after final LRTI. Conclusions.: Infants with CF incurring respiratory virus infection are at significant risk for LRTI, for hospitalization, and for deterioration in lung function that persists months after the acute illness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Gibson, R. L., Burns, J. L., & Ramsey, B. W. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200304-505so · Cited by 1,633
Respiratory Syncytial Virus and Parainfluenza Virus
Hall, C. B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106213442507 · Cited by 1,233
The Changing Microbial Epidemiology in Cystic Fibrosis
LiPuma, J. J. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00068-09 · Cited by 806
The role of particle size in aerosolised pathogen transmission: a review
Gralton, J., Tovey, E., McLaws, M.-L., & Rawlinson, W. D. (2011) · Journal of Infection · doi:10.1016/j.jinf.2010.11.010 · Cited by 665
Exacerbations in cystic fibrosis {middle dot} 1: Epidemiology and pathogenesis
Goss, C. H., & Burns, J. L. (2007) · Thorax · doi:10.1136/thx.2006.060889 · Cited by 445
Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis
Hauser, A. R., Jain, M., Bar-Meir, M., & McColley, S. A. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-10 · Cited by 411
Normal and Cystic Fibrosis Airway Surface Liquid Homeostasis
Tarran, R., Button, B., Picher, M., Paradiso, A. M., Ribeiro, C. M., Lazarowski, E. R., Zhang, L., Collins, P. L., Pickles, R. J., Fredberg, J. J., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505832200 · Cited by 345
Infection Control in Cystic Fibrosis
Saiman, L., & Siegel, J. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.1.57-71.2004 · Cited by 324
Saiman, L. (2003) · American Journal of Infection Control · doi:10.1067/mic.2003.78 · Cited by 307
Early intervention and prevention of lung disease in cystic fibrosis: a European consensus
Döring, G., & Hoiby, N. (2004) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2004.03.008 · Cited by 304
Respiratory Syncytial Virus Infections in Previously Healthy Working Adults
Hall, C. B., Long, C. E., & Schnabel, K. C. (2001) · Clinical Infectious Diseases · doi:10.1086/322657 · Cited by 254
Hendricks, M. R., Lashua, L. P., Fischer, D. K., Flitter, B. A., Eichinger, K. M., Durbin, J. E., Sarkar, S. N., Coyne, C. B., Empey, K. M., & Bomberger, J. M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516979113 · Cited by 168
Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation?
Stressmann, F. A., Rogers, G. B., Marsh, P., Lilley, A. K., Daniels, T. W. V., Carroll, M. P., Hoffman, L. R., Jones, G., Allen, C. E., Patel, N., et al. (2011) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2011.05.002 · Cited by 130
“Changes in the bacterial mode of growth [44], the occurrence of respiratory viral infections [4,8,45,46], or changes in the expression of virulence [47], might also be triggers of CFPE.”
BackgroundZheng, S., De, B. P., Choudhary, S., Comhair, S. A. A., Goggans, T., Slee, R., Williams, B. R. G., Pilewski, J., Haque, S. J., & Erzurum, S. C. (2003) · Immunity · doi:10.1016/s1074-7613(03)00114-6 · Cited by 125
RSV Mediates Pseudomonas aeruginosa Binding to Cystic Fibrosis and Normal Epithelial Cells
van Ewijk, B. E., Wolfs, T. F. W., Aerts, P. C., Van Kessel, K. P. M., Fleer, A., Kimpen, J. L. L., & Van Der Ent, C. K. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e3180332d1c · Cited by 113
“Although the prevalence of viral infections seems to be equal in CF patients and healthy controls (3,4), CF patients are more likely to develop a lower respiratory tract infection with more and prolonged symptoms (3,5,6).”
BackgroundRole of epithelial nitric oxide in airway viral infection
Xu, W., Zheng, S., Dweik, R. A., & Erzurum, S. C. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.01.037 · Cited by 85
Metadata
- Authors
- Hiatt, P. W., Grace, S. C., Kozinetz, C. A., Raboudi, S. H., Treece, D. G., Taber, L. H., & Piedra, P. A.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 1999-03-01
- Volume
- 103
- Issue
- 3
- Pages
- 619-626
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2048204433
- Cited by
- 215
- References
- 0
- FWCI
- 7.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.